tm logo
CANECT-HD
FORMALIZED

on 25 Jan 2024

Last Applicant/ Owned by

NEUROCRINE BIOSCIENCES INC.

12780 El Camino RealSan Diego, CA 92130

US

Serial Number

2306553 filed on 25th Jan 2024

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

CANECT-HD

Trademark usage description

providing medical research information in the field of pharmaceuticals and clinical trials focusing on huntington's disease, chorea associated with hu Read More

Classification Information


Class [042]
Providing medical research information in the field of pharmaceuticals and clinical trials focusing on Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Conducting research in the field of pharmaceuticals for evaluating epidemiological results; Conducting research in the field of pharmaceuticals for evaluating patients in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders


Classification kind code

12

Class [044]
Providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Online information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Providing pharmaceutical consultancy services


Classification kind code

12

Mark Details


Serial Number

2306553

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 08th Feb 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 25th Jan 2024
Filed
Submitted for opposition 1
on 25th Jan 2024
Created
Submitted for opposition 31
on 25th Jan 2024
Formalized